At Nervana Medical, we require a consultation to assess whether you’re a good candidate for ketamine infusion treatment for depression, anxiety, PTSD, and other mental health conditions. You will meet with a member of our experienced medical team to ensure this treatment is safe for you.
Ketamine Treatment Appointment Instructions
- Please have someone available to drive you home after the infusion
- Plan to be at the clinic 1.5 hours minimum for a 40 min infusion or 5 hours for a 4-hour infusion
- Please do not eat 8 hours before the infusion
- You may drink 2 hours before the infusion
- Avoid benzodiazepines (for example, Xanax and Ativan) and marijuana on the day of your procedure
- Do not take opioid pain medications 6 hours before the procedure
We recommend finding a soothing music playlist to listen to during your infusion, as it can help with its calming effects. We recommend music specific to psychedelic ketamine therapy. You are welcome to bring your own headphones, eye mask, and blanket as well, though we will have these accommodations available should you need them.
Ketamine Patient FAQs
Ketamine Scheduling/Survey Information
We track your progress by administering three simple surveys before each ketamine treatment in Sandy. The three surveys we utilize are: a self-assessed mood score, a more in-depth PHQ-9 to benchmark and monitor overall depression symptoms, and the GAD generalized anxiety disorder survey. Please answer the questions to the best of your ability, as we actively collect data to continue improving future research/best practice standards, and protocols.
After completing your initial paperwork and first survey, you will need to schedule a medical history and exam clearance appointment prior to your first infusion. The cost of this exam is $50 and does not include lab costs if labs are indicated (primarily for patients with a history of extensive comorbidities or those interested in chronic pain infusion therapy). If you and the provider decide to pursue a series of six infusions, the $50 exam fee is applied to the cost of the infusions. If you have had a recent physical exam, then you are welcome to email it to us for our review, and this fee will be waived.
Scheduling
Our mental health protocol recommends 6 infusions over 2 weeks (please ensure you are able to block off time to ensure you are able to complete the recommended protocol). If you desire your current therapist to be present during the infusion for psychotherapy assistance, you will need to arrange that with them. If they are unable to attend but you would still like psycho assisted therapy during your infusion, then we are happy to provide you with referrals (the price of this would be dependent upon the therapist).
- Appointment 1 – Medical History and Exam/Clearance
- Appointment 2 – Infusion #1
- Appointment 3 – Infusion #2
- Appointment 4 – Infusion #3
- Appointment 5 – Infusion #4
- Appointment 6 – Infusion #5
- Appointment 7 – Infusion #6
We will provide you with a recommended book list that we find useful to accompany your infusions as you pursue the journey of improving your mental health. Please consider looking into these books in further detail, as they can be beneficial in your overall progress.
Nervana’s Ketamine Mental Health Protocol Rationale
References:
Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67(2):362-70. doi: 10.1016/j.mehy.2006.01.047. Epub 2006 Mar 20. PMID: 16542786.
Eby GA 3rd, Eby KL. Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses. 2010 Apr;74(4):649-60. doi: 10.1016/j.mehy.2009.10.051. Epub 2009 Nov 27. PMID: 19944540.
Menon V, Kar SK, Suthar N, Nebhinani N. Vitamin D and Depression: A Critical Appraisal of the Evidence and Future Directions. Indian J Psychol Med. 2020 Jan 6;42(1):11-21. doi: 10.4103/IJPSYM.IJPSYM_160_19. PMID: 31997861; PMCID: PMC6970300.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352515
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351-354.https://doi.org/10.1016/S0006-3223(99)00230-9
Beurel, E., Toups, M., & Nemeroff, C. B. (2020). The bidirectional relationship of depression and inflammation: double trouble. Neuron, 107(2), 234-256. https://doi.org/10.1016/j.neuron.2020.06.002
Dell’Osso, L., Carmassi, C., Mucci, F., & Marazziti, D. (2016). Depression, serotonin and tryptophan. Current Pharmaceutical Design, 22(8), 949-954. https://doi.org/10.2174/1381612822666151214104826
Grant, R., Berg, J., Mestayer, R., Braidy, N., Bennett, J., Broom, S., & Watson, J. (2019). A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD. Frontiers in Aging Neuroscience, 11, 257. https://doi.org/10.3389/fnagi.2019.00257
Kopra, E., Mondelli, V., Pariante, C., & Nikkheslat, N. (2021). Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review. Journal of Psychopharmacology, 35(8), 934-945.https://doi.org/10.1177/02698811211026426
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. (2019). Ketamine: a paradigm shift for depression research and treatment. Neuron, 101(5), 774-778. https://doi.org/10.1016/j.neuron.2019.02.005
Morris, G., Walder, K. R., Berk, M., Marx, W., Walker, A. J., Maes, M., & Puri, B. K. (2020). The interplay between oxidative stress and bioenergetic failure in neuropsychiatric illnesses: can we explain it and can we treat it?. Molecular Biology Reports, 47(7), 5587-5620. https://doi.org/10.1007/s11033-020-05590-5
National Institute of Mental Health (2022). Major depression. National Institute of Mental Health. Retrieved February 24, 2022, from https://www.nimh.nih.gov/health/statistics/major-depression
Ogyu, K., Kubo, K., Noda, Y., Iwata, Y., Tsugawa, S., Omura, Y., … & Nakajima, S. (2018). Kynurenine pathway in depression: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 90, 16-25. https://doi.org/10.1016/j.neubiorev.2018.03.023
Roy, A., & Campbell, M. K. (2013). A unifying framework for depression: bridging the major biological and psychosocial theories through stress. Clinical and Investigative Medicine, E170-E190. https://doi.org/10.25011/cim.v36i4.19951
Wilkinson, S. T., Toprak, M., Turner, M. S., Levine, S. P., Katz, R. B., & Sanacora, G. (2017). A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders. American Journal of Psychiatry, 174(7), 695-696. https://doi.org/10.1176/appi.ajp.2017.17020239
Yoshino, M., Yoshino, J., Kayser, B. D., Patti, G. J., Franczyk, M. P., Mills, K. F., … & Klein, S. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224-1229. https://doi.org/10.1126/science.abe9985